145 related articles for article (PubMed ID: 11140876)
21. Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer.
Chicken DW; Kocjan G; Falzon M; Lee AC; Douek M; Sainsbury R; Keshtgar MR
Br J Surg; 2006 May; 93(5):572-6. PubMed ID: 16550634
[TBL] [Abstract][Full Text] [Related]
22. Update on detection of sentinel lymph nodes in patients with breast cancer.
Aarsvold JN; Alazraki NP
Semin Nucl Med; 2005 Apr; 35(2):116-28. PubMed ID: 15765374
[TBL] [Abstract][Full Text] [Related]
23. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic mapping and sentinel node biopsy: a surgical perspective.
Kaleya RN; Heckman JT; Most M; Zager JS
Semin Nucl Med; 2005 Apr; 35(2):129-34. PubMed ID: 15765375
[TBL] [Abstract][Full Text] [Related]
25. Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer.
Nasioudis D; Albright BB; Roy A; Ko EM; Giuntoli RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Latif NA
Gynecol Oncol; 2020 Dec; 159(3):732-736. PubMed ID: 33004215
[No Abstract] [Full Text] [Related]
26. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.
Cody HS
Ann Surg; 2006 Aug; 244(2):324; author reply 324-5. PubMed ID: 16858198
[No Abstract] [Full Text] [Related]
27. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
Giuliano AE; Kirgan DM; Guenther JM; Morton DL
Ann Surg; 1994 Sep; 220(3):391-8; discussion 398-401. PubMed ID: 8092905
[TBL] [Abstract][Full Text] [Related]
28. Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
Azghadi S; Daly M; Mayadev J
Clin Breast Cancer; 2016 Oct; 16(5):410-417.e3. PubMed ID: 27266803
[TBL] [Abstract][Full Text] [Related]
29. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
[TBL] [Abstract][Full Text] [Related]
30. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?
Sanidas EE; de Bree E; Tsiftsis DD
Am J Surg; 2003 Mar; 185(3):202-10. PubMed ID: 12620556
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer.
Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E
Breast J; 2006; 12(3):199-201. PubMed ID: 16684315
[TBL] [Abstract][Full Text] [Related]
32. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
33. Pathologic analysis of the sentinel lymph node.
Treseler PA; Tauchi PS
Surg Clin North Am; 2000 Dec; 80(6):1695-719. PubMed ID: 11140868
[TBL] [Abstract][Full Text] [Related]
34. Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients.
Sanjuàn A; Vidal-Sicart S; Zanón G; Pahisa J; Velasco M; Fernández PL; Santamaría G; Farrús B; Muñoz M; Albanell J; Pons F; Vanrell JA
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):932-6. PubMed ID: 15791433
[TBL] [Abstract][Full Text] [Related]
35. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
36. Re: "acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky," by Conn et al.
Cady B
Breast J; 2005; 11(4):229-30. PubMed ID: 15982386
[No Abstract] [Full Text] [Related]
37. Sentinel lymph node biopsy in melanoma.
Uren RF
J Nucl Med; 2006 Feb; 47(2):191-5. PubMed ID: 16455622
[No Abstract] [Full Text] [Related]
38. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates.
McCready DR; Yong WS; Ng AK; Miller N; Done S; Youngson B
J Natl Cancer Inst; 2004 Jun; 96(11):873-5. PubMed ID: 15173271
[TBL] [Abstract][Full Text] [Related]
39. [Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation].
Serrano Vicente J; Infante de la Torre JR; Domínguez Grande ML; García Bernardo L; Durán Barquero C; Rayo Madrid JI; Sánchez Sánchez R; Correa Antúnez MI; Amaya Lozano JL; Conde Martín AF
Rev Esp Med Nucl; 2010; 29(1):8-11. PubMed ID: 20015577
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
